Hypersomnia Clinical Trial
Official title:
Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy
1. To determine the effects of transcranial direct current stimulation (tDCS) on vigilance in subjects with central hypersomnia without cataplexy. 2. To determine the effects of tDCS on subjective measures of sleepiness and alertness in subjects with central hypersomnia without cataplexy.
This is a randomized, sham-controlled, parallel group study. The study will last up to 5 weeks. After informed consent, subjects with idiopathic hypersomnia with an MSLT mean sleep latency of >8 minutes will undergo actigraphy and those with an average sleep time of >10 hours per day will continue with the study while those with <10 hours sleep time will be excluded. In addition, OSA subjects with complaints of hypersomnia with an ESS score <10 will also be excluded. Female subjects of child bearing age and not menopausal will have a pregnancy test performed as pregnancy is an exclusionary criteria. Subjects will be randomized to receive either active tDCS or sham stimulation for 30 minutes daily for 4 sessions. The randomization will be generated by means of a computer-generated random-number table. An unrestricted randomization scheme will be followed. Subjects will be blinded as to whether they are receiving sham or active tDCS treatments. The investigator who will conduct the analysis of all outcomes will be blinded as to subject treatment assignment. All stimulation visits will be completed within a five-consecutive day period; that is one stimulation visit may be missed provided a total of four stimulation visits are completed within a five-day period. Outcome measures will include: psychomotor vigilance test (PVT), subjective measures of sleepiness, and the Center for Epidemiologic Studies Depression (CES-D) scale. PVT will be performed pre- and post- stimulation during the first and last stimulation sessions. Subjective measures of sleepiness include the following: Epworth Sleepiness Scale (ESS), Stanford Sleepiness Scale (SSS), Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10), and Visual Analogue Scale (VAS). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05983731 -
A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment
|
||
Withdrawn |
NCT03626727 -
Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
|
Early Phase 1 | |
Completed |
NCT01183312 -
Flumazenil for the Treatment of Primary Hypersomnia
|
Phase 1/Phase 2 | |
Completed |
NCT03682185 -
The Healthy Patterns Sleep Study
|
Phase 3 | |
Completed |
NCT00916253 -
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies
|
N/A | |
Completed |
NCT04157244 -
The Music, Sleep and Dementia Study
|
N/A | |
Recruiting |
NCT05443373 -
A Multi-Signal Based Monitoring System for CNS Hypersomnias
|
||
Completed |
NCT01877616 -
Sleep Disorders and Their Cardiovascular Correlates in Atahualpa.
|
N/A | |
Suspended |
NCT00427323 -
Light Exposure to Treat Sleep Disruption in Older People
|
N/A | |
Not yet recruiting |
NCT04300166 -
Telemedicine and Humidification for Cpap IN Osas Key Treatment (THINK Study)
|
N/A | |
Not yet recruiting |
NCT06404086 -
RECOVER-SLEEP: Platform Protocol
|
Phase 2 | |
Not yet recruiting |
NCT06404099 -
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
|
Phase 2 | |
Completed |
NCT01146600 -
Clarithromycin for the Treatment of Hypersomnia
|
Phase 2 | |
Withdrawn |
NCT05627388 -
Feasibility Study of At-Home EEG Monitoring for Hypersomnia
|
N/A | |
Completed |
NCT01764035 -
Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder
|
N/A | |
Completed |
NCT03459300 -
Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)
|
||
Completed |
NCT00001664 -
Sleep Disorders of Patients With Diseases of the Nervous System
|
N/A | |
Recruiting |
NCT04201392 -
Sleep in Psychiatric Inpatients
|
||
Suspended |
NCT05230394 -
Patient Outcomes in Unattended and In- Lab Polysomnography
|
N/A | |
Terminated |
NCT01544465 -
Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease
|
N/A |